Zeinab Aryanian; Azar Shirzadian; Faezeh Bakhshinasab; Soheil Ebrahim Pour; Arefeh Babazadeh; Zeinab Mohseni Afshar; Azadeh Goodarzi; Zahra Nikyar; Parvaneh Hatami
Abstract
Background: During the recent coronavirus disease 2019 (COVID-19) pandemic, we witnessed an increased incidence of contact dermatitis in the hands and other body areas of healthcare workers secondary to using antiseptics and personal protective equipment. This study aimed to investigate the prevalence ...
Read More
Background: During the recent coronavirus disease 2019 (COVID-19) pandemic, we witnessed an increased incidence of contact dermatitis in the hands and other body areas of healthcare workers secondary to using antiseptics and personal protective equipment. This study aimed to investigate the prevalence of skin lesions in healthcare workers in hospitals affiliated with Babol University of Medical Sciences during the COVID-19 pandemic.Methods: In a cross-sectional study, the healthcare workers of Ayatollah Rouhani, Shahid Yahya Nejad, and Shahid Beheshti hospitals in Babol, Iran, were asked to fill out information collection forms about cutaneous lesions during the COVID-19 pandemic.Results: Three hundred healthcare workers were included in the study. Skin lesions were seen in 240 patients (80%), and the hands were the most common site of involvement (36.7%). Skin lesions in healthcare workers had no statistically significant relationship with the variables of age (P = 0.84), sex (P = 0.52), and COVID-19-dedicated wards (P = 0.16). However, skin lesions were more common in those with more working hours (P = 0.01) and increased handwashing frequency (P < 0.001).Conclusion: The present study showed a high prevalence of skin lesions among hospital healthcare workers during the COVID-19 pandemic. Therefore, preventive measures are recommended.
Parvaneh Hatami; Zeinab Aryanian; Hamed Nicknam Asl; Azadeh Goodarzi
Abstract
Since coronavirus disease 2019 (COVID-19) vaccines were approved without long-term monitoring, tracking their adverse effects appears to be necessary. Mucocutaneous adverse events are of great importance due to their visibility and the potential effect on inducing fear in patients leading to vaccine ...
Read More
Since coronavirus disease 2019 (COVID-19) vaccines were approved without long-term monitoring, tracking their adverse effects appears to be necessary. Mucocutaneous adverse events are of great importance due to their visibility and the potential effect on inducing fear in patients leading to vaccine hesitancy. We searched PubMed, Google Scholar, and Scopus in this regard, and all of the relevant papers published until June 28, 2021, were included if we could access their full texts. Moreover, we included some of our cases from Iran. We found various mucocutaneous manifestations after COVID-19 vaccination, including local injection site reactions (acute or delayed), urticarial lesions, pityriasis rosea-like rashes, angioedema, morbilliform rashes, pernio-like lesions, acrocyanosis, petechial/ purpuric/ecchymotic lesions, herpes flare-up, herpetiform rashes, oral erosive lesions, acral pustular rashes, erythema multiform, dermographism, herpes zoster, generalized pruritus, contact dermatitis, reaction to dermal fillers and non-specific rashes. We categorized them by their time of initiation (acute or delayed) and site of involvement (local injection site, remote area, or generalized). Delayed local reactions, local injection site reactions, urticarial lesions, and pityriasis rosea-like and morbilliform rashes were among the most common cutaneous adverse events. Dermatologists should be aware of these potential reactions to manage them properly, reassure patients, and encourage them to continue their vaccination.
